Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,405 | -36,908 | -28,292 | -20,814 | -19,764 |
| Depreciation Amortization | 757 | 188 | N/A | N/A | 4,284 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 11,430 |
| Accounts receivable | N/A | N/A | N/A | N/A | 2,816 |
| Accounts payable and accrued liabilities | 1,089 | 63 | 606 | 118 | 1,494 |
| Other Working Capital | 1,439 | -3,509 | 1,506 | 243 | 11,971 |
| Other Operating Activity | 4,405 | 2,055 | -671 | 32 | -4,267 |
| Operating Cash Flow | $-53,715 | $-38,111 | $-26,851 | $-20,421 | $7,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,252 | -83,290 | N/A | N/A | N/A |
| PPE Investments | -843 | N/A | N/A | N/A | -1,446 |
| Sale Of Investment | 30,780 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $61,189 | $-83,290 | $N/A | $N/A | $-1,446 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | N/A | N/A | 115,452 |
| Debt Repayment | N/A | N/A | N/A | N/A | -121,936 |
| Common Stock Issued | N/A | 67,712 | N/A | N/A | N/A |
| Other Financing Activity | 146 | 82,559 | 18,977 | 10,926 | 0 |
| Financing Cash Flow | $146 | $160,271 | $18,977 | $10,926 | $-6,484 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -118 |
| Beginning Cash Position | 43,075 | 4,205 | 12,079 | 21,574 | 1,547 |
| End Cash Position | 50,695 | 43,075 | 4,205 | 12,079 | 1,463 |
| Net Cash Flow | $7,620 | $38,870 | $-7,874 | $-9,495 | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,715 | -38,111 | -26,851 | -20,421 | 7,964 |
| Capital Expenditure | -843 | N/A | N/A | N/A | -1,522 |
| Free Cash Flow | -54,558 | -38,111 | -26,851 | -20,421 | 6,442 |